---
title: "IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278614489.md"
description: "IDEXX Laboratories Inc. (IDXX) shares fell 1.90% to $598.85 on Tuesday, underperforming in a generally weak stock market, with the S&P 500 down 0.21% and the Dow Jones down 0.07%. The stock is currently 22.23% below its 52-week high of $769.98. In comparison, Johnson & Johnson rose 0.46%, while Medtronic and Boston Scientific saw declines of 1.59% and 2.70%, respectively."
datetime: "2026-03-10T20:50:44.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278614489.md)
  - [en](https://longbridge.com/en/news/278614489.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278614489.md)
---

# IDEXX Laboratories Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of IDEXX Laboratories Inc. (IDXX) shed 1.90% to $598.85 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index falling 0.21% to 6,781.48 and Dow Jones Industrial Average falling 0.07% to 47,706.51.

IDEXX Laboratories Inc. closed 22.23% short of its 52-week high of $769.98, which the company reached on November 26th.

The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as Johnson & Johnson (JNJ) rose 0.46% to $243.71, Medtronic PLC (MDT) fell 1.59% to $89.89, and Boston Scientific Corp. (BSX) fell 2.70% to $69.96.

Data source: Dow Jones Market Data, FactSet. Data compiled March 10, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

03-10-26 1650ET

### Related Stocks

- [IDXX.US](https://longbridge.com/en/quote/IDXX.US.md)

## Related News & Research

- [Third View Private Wealth LLC Invests $1.21 Million in IDEXX Laboratories, Inc. $IDXX](https://longbridge.com/en/news/282676193.md)
- [IDEXX Laboratories to Release 2026 First Quarter Financial Results | IDXX Stock News](https://longbridge.com/en/news/282074803.md)
- [BUZZ-J.P. Morgan upbeat on animal health companies ahead of Q1 results](https://longbridge.com/en/news/282019577.md)
- [Adaigo Medical Receives FDA IDE Approval To Study Next-Generation VCLAS Ventricular Ablation System](https://longbridge.com/en/news/282050466.md)
- [Idexx Laboratories (IDXX) Valuation Check After New Cancer Dx Panel Launch In The United Kingdom](https://longbridge.com/en/news/281429733.md)